Autologous Wound Therapy, Inc. Announces New Symbol for Its Stock Traded On the OTC Bulletin Board.

LITTLE ROCK, Ark.--(BUSINESS WIRE)--Nov. 8, 1999--

Autologous autologous /au·tol·o·gous/ (aw-tol´ah-gus) related to self; belonging to the same organism.

au·tol·o·gous
adj.
1. Wound Therapy, Inc., (formerly Informatix Holdings, Inc. OTCBB OTCBB

See OTC Bulletin Board (OTCBB). : IFXH) ("Autologous") today announced that its securities which are traded on The OTC Bulletin Board OTC Bulletin Board

An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. will be traded under the symbol AWTX.

Autologous holds the patent (pending), trademark and rights to the process that enables physicians to create Autolo-Gel which will be made available to medical facilities for the treatment of chronic non-healing wounds, including diabetic ulcers, venous stasis venous stasis Medtalk The pooling of venous blood in a particular region which, in the legs results in edema, hyperpigmentation and possibly ulceration wounds and pressure ulcers.

COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Publication:	Business Wire
Date:	Nov 8, 1999
Words:	80
Previous Article:	Symantec and On the Go Software Make Tracking Expenses Easy in Act! 2000.
Next Article:	CollegeClub.com Acquires Collegestudent.com to Create Student `Mega-Portal'.

Related Articles
Famous Fixins Stock Now Trading Under "FIXNE" Symbol.
Informatix Holdings, Inc. Announces Signing of a Definitive Merger Agreement and Plan of Reorganization With Autologous Wound Therapy, Inc.
Informatix Holdings, Inc. Announces Closing of Merger With Autologous Wound Therapy, Inc.
Famous Fixins Stock Now Trading Under "FIXNE" Symbol (2).
Autologous Wound Therapy, Inc. Announces Results of Independent Evaluation of the Autolo-Cure Process.
AuTologous Wound Therapy, Inc. Announces Completion of $6,500,000.00 Private Placement of Common Stock.
AuTologous Wound Therapy, Inc. Announces Name Change to Cytomedix, Inc.
Cytomedix Grants Turning Point Wound Management Services the Non-Exclusive Distribution Rights for Its Proprietary Product, AutoloGel.
Cytomedix, Inc.: Reverse Stock Split and New Stock Symbol.
Cytomedix, Inc. Announces Listing on NASDAQ OTC Bulletin Board.